We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current APL market cap is 5.93M. The company's latest EPS is AUD -0.0351 and P/E is -2.85.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 7.31M | 4.62M | 5.51M | 6.1M | 5.51M |
| Operating Income | -4.89M | -1.39M | -896k | -646k | -2.01M |
| Net Income | -5.21M | -1.16M | -800k | -642k | -1.99M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 14.72M | 13.34M | 13.86M | 13.21M | 13.09M |
| Total Liabilities | 3.81M | 3.56M | 4.48M | 4.31M | 6.01M |
| Total Equity | 10.91M | 9.79M | 9.37M | 8.9M | 7.08M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.13M | -1.23M | -307k | -824k | -2.16M |
| Investing | 153k | -17k | 1.82M | 1.82M | -307k |
| Financing | N/A | 750k | 70k | 76k | -71k |
| Market Cap | 5.93M |
| Price to Earnings Ratio | -2.85 |
| Price to Sales Ratio | 1.02 |
| Price to Cash Ratio | 1.39 |
| Price to Book Ratio | 0.8 |
| Dividend Yield | - |
| Shares Outstanding | 56.49M |
| Average Volume (1 week) | 20k |
| Average Volume (1 Month) | 13.61k |
| 52 Week Change | -65.00% |
| 52 Week High | 0.33 |
| 52 Week Low | 0.07 |
| Spread (Intraday) | 0.06 (36.36%) |
| Company Name | Associate Global Partners Ltd |
| Address |
level 12, 2 chifley square sydney, new south wales 2000 |
| Website | https://www.associateglobal.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
